|
|
Volumn 4, Issue 1, 2002, Pages 29-36
|
|
Evolving therapies: farnesyltransferase inhibitors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
FARNESYL TRANS TRANSFERASE;
ISOPROTEIN;
RAS PROTEIN;
TRANSFERASE;
ANIMAL;
CHEMICAL MODEL;
CHEMISTRY;
CLINICAL TRIAL;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
ENZYME SPECIFICITY;
GENETICS;
HUMAN;
MUTATION;
NEOPLASM;
PROTEIN PROCESSING;
REVIEW;
ALKYL AND ARYL TRANSFERASES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DISEASE MODELS, ANIMAL;
DRUG DESIGN;
ENZYME INHIBITORS;
FARNESYLTRANSTRANSFERASE;
HUMANS;
MODELS, CHEMICAL;
MUTATION;
NEOPLASMS;
PROTEIN ISOFORMS;
PROTEIN ISOPRENYLATION;
RAS PROTEINS;
SUBSTRATE SPECIFICITY;
|
|
EID: 0036134355
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-002-0045-8 Document Type: Review |
|
Times cited : (34)
|
|
References (62)
|
